Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Applied Biosystems Axiom Asia Precision Medicine Research Array

Thermo Fisher Scientific has launched the Applied Biosystems Axiom Asia Precision Medicine Research Array. The array contains more than 750,000 biomarkers associated with both common and rare diseases, including more than 100,000 variants shown to have pathogenic effects in East Asian and South Asian populations. In addition, 50,000 custom markers can be added. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.